ROBERT JOSEPH COLLINS MD NPI 1225477425

NPI Details

Robert Joseph Collins, MD is an internal medicine in Columbia, SC with 13 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Robert Joseph Collins, MD NPI is 1225477425. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE
Graduation Year:2013

The provider's business location address is:

1801 SUNSET
INTERNAL MEDICINE
COLUMBIA, SC
ZIP 29203
Phone: (803) 434-4197
Fax: (803) 434-4160

The NPI 1225477425 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, gadobutrol, 0.1 ml (HCPCS:A9585)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver function blood test panel (HCPCS:80076)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, fulvestrant, 25 mg (HCPCS:J9395)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Ferritin (blood protein) level (HCPCS:82728)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of chest with contrast (HCPCS:71260)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Red blood count, manual test (HCPCS:85044)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Application of on-body injector for under skin injection (HCPCS:96377)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Ct scan of chest without contrast (HCPCS:71250)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Unclassified drugs (HCPCS:J3490)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Magnesium level (HCPCS:83735)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Folic acid level, serum (HCPCS:82746)
• X-ray of chest, 2 views (HCPCS:71046)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Mri scan of abdomen before and after contrast (HCPCS:74183)
• 5% dextrose/water (500 ml = 1 unit) (HCPCS:J7060)
• Mri scan of brain before and after contrast (HCPCS:70553)
• Blood test, clotting time (HCPCS:85610)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Nuclear medicine study whole body with ct scan (HCPCS:78816)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Mri scan of both breasts (HCPCS:77049)
• Urinalysis using microscope (HCPCS:81015)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Total protein level, urine (HCPCS:84156)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Hospital discharge day management, 30 minutes or less (HCPCS:99238)
• Complete x-ray of body bones (HCPCS:77075)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 6/20/2013 and was last updated on 6/20/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: